4.6 Article

Quantification of plasma phosphorylated tau to use as a biomarker for brain Alzheimer pathology: pilot case-control studies including patients with Alzheimer's disease and down syndrome

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Clinical Neurology

Plasma concentrations of free amyloid β cannot predict the development of Alzheimer's disease

Hugo Lovheim et al.

ALZHEIMERS & DEMENTIA (2017)

Article Clinical Neurology

Biomarkers of AD risk — the end of the road for plasma amyloid-β?

Heather Wood

Nature Reviews Neurology (2016)

Article Clinical Neurology

Plasma tau in Alzheimer disease

Niklas Mattsson et al.

NEUROLOGY (2016)

Article Clinical Neurology

Cerebrospinal fluid tau and amyloid-β1-42 in patients with dementia

Tobias Skillback et al.

Article Biochemistry & Molecular Biology

Plasma Aβ but Not Tau is Related to Brain PiB Retention in Early Alzheimer's Disease

Kai-Yuan Tzen et al.

ACS CHEMICAL NEUROSCIENCE (2014)

Article Biochemistry & Molecular Biology

Evaluation of Selenium, Redox Status and Their Association with Plasma Amyloid/Tau in Alzheimer's Disease

Sreeram Krishnan et al.

BIOLOGICAL TRACE ELEMENT RESEARCH (2014)

Article Geriatrics & Gerontology

The efficacy of plasma biomarkers in early diagnosis of Alzheimer's disease

Tao Wang et al.

INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2014)

Review Clinical Neurology

Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria

Bruno Dubois et al.

LANCET NEUROLOGY (2014)

Article Medicine, General & Internal

Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease

Stephen Salloway et al.

NEW ENGLAND JOURNAL OF MEDICINE (2014)

Article Biochemistry & Molecular Biology

Combined Plasma Biomarkers for Diagnosing Mild Cognition Impairment and Alzheimer's Disease

Ming-Jang Chiu et al.

ACS CHEMICAL NEUROSCIENCE (2013)

Article Clinical Neurology

Preclinical Alzheimer's disease and its outcome: a longitudinal cohort study

Stephanie J. B. Vos et al.

LANCET NEUROLOGY (2013)

Letter Clinical Neurology

Plasma tau levels in Alzheimer's disease

Henrik Zetterberg et al.

ALZHEIMERS RESEARCH & THERAPY (2013)

Article Medicine, General & Internal

Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease

Randall J. Bateman et al.

NEW ENGLAND JOURNAL OF MEDICINE (2012)

Article Neurosciences

Plasma Amyloid-beta as a Biomarker in Alzheimer's Disease: The AIBL Study of Aging

James K. Lui et al.

JOURNAL OF ALZHEIMERS DISEASE (2010)

Article Biotechnology & Applied Microbiology

Single-molecule enzyme-linked immunosorbent assay detects serum proteins at subfemtomolar concentrations

David M. Rissin et al.

NATURE BIOTECHNOLOGY (2010)

Article Clinical Neurology

Cerebrospinal Fluid Biomarker Signature in Alzheimer's Disease Neuroimaging Initiative Subjects

Leslie M. Shaw et al.

ANNALS OF NEUROLOGY (2009)

Article Clinical Neurology

CSF tau protein: A new prognostic marker for Guillain-Barre syndrome

K. Jin et al.

NEUROLOGY (2006)

Article Biochemistry & Molecular Biology

Amyloid precursor protein and amyloid β peptide in human platelets -: Role of cyclooxygenase and protein kinase C

DM Skovronsky et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2001)